Oncolytics Biotech (ONCY) Intangibles (2009)
Oncolytics Biotech's Intangibles came in at $240,516 for Q3 2025, up 224.9% from $74,038 a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Intangibles (2009) Analysis & Trends
At the end of FY2011, Oncolytics Biotech's Intangibles was $299,699, down 12.8% from FY2010.
- Going back by year, Intangibles was $343,764 in FY2010.
- The Q3 2025 figure represents the highest quarterly Intangibles since Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Oncolytics Biotech | 62.32 Mn | 33.44 Mn | - | - |
API Access
Oncolytics Biotech Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();